Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay
- 1 November 1997
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 45 (2) , 175-182
- https://doi.org/10.1016/s0167-8140(97)00110-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicityRadiotherapy and Oncology, 1995
- Administration of nicotinamide during chart: Pharmacokinetics, dose escalation, and clinical toxicityInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Carbogen breathing with nicotinamide improves the oxygen status of tumours in patientsBritish Journal of Cancer, 1995
- Nicotinamide and Other Benzamide Analogs as Agents for Overcoming Hypoxic Cell Radiation Resistance in TumoursActa Oncologica, 1995
- The Effect of Nicotinamide on Microregional Blood Flow Within Tumours Assessed Using Laser Doppler ProbesActa Oncologica, 1995
- Nicotinamide and Carbogen: Relationship betweenpO2and Radiosensitivity in Three Tumour LinesInternational Journal of Radiation Biology, 1994
- Nicotinamide exerts different acute effects on microcirculatory function and tissue oxygenation in rat tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Preferential tumor radiosensitization by analogs of nicotinamide and benzamideInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Nicotinamide as a radiosensitizer of a C3H mouse mammary adenocarcinomaRadiotherapy and Oncology, 1984
- Tissue NAD Levels and the Response to Irradiation or Cytotoxic DrugsBritish Journal of Cancer, 1970